$49.73 1.43 (+2.96%)
2/13/2012 4:00 PM

Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

2
Player Avatar GunnarVagotis (96.02) Submitted: 6/24/2008 10:49:45 AM : Underperform Start Price: $6.86 JAZZ Score: +44.04

I suspect this company got its ticker symbol before it came up with a business plan.

Report this Post Add Comment

Featured Broker Partners


Advertisement